Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 18 INDUSTRY 8 OTHER_GOV 1 NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 11 Neoplasm Metastasis 6 Stomach Neoplasms 5 Small Cell Lung Carcinoma 2 Rectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction 2 Sarcoma 1 Recurrence 1 Lung Neoplasms 1 Gastrointestinal Neoplasms 1 Gastro-enteropancreatic neuroendocrine tumor 1 Colonic Neoplasms 1 Breast Neoplasms 1 Breast Cancer Metastatic 1

Interventions

Tamoxifen 10 Docetaxel 8 Trastuzumab 7 Paclitaxel 6 Letrozole 6 Gemcitabine 6 Exercise 6 Control Groups 6 exemestane 5 Indocyanine Green 5 Cyclophosphamide 5 Carboplatin 5 Anastrozole 5 pertuzumab 4 dalpiciclib 4 Vinorelbine 4 Doxorubicin 4 Capecitabine 4 pyrotinib 3 Surgical Procedures, Operative 3 Standard of Care 3 Radiotherapy 3 Radiation 3 Mammography 3 Fulvestrant 3 Cisplatin 3 ferumoxides 2 Zoledronic Acid 2 Tablets 2 Surveys and Questionnaires 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Breast Neoplasms × Irinotecan × Clear all

NCT01501669 2012-07-18

PROCEED

National Cancer Center, Korea

Phase 3 Unknown

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡